Spots Global Cancer Trial Database for megestrol acetate
Every month we try and update this database with for megestrol acetate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate | NCT00483327 | Atypical Endome... Endometrial Car... | Megestrol Aceta... | 18 Years - | NYU Langone Health | |
| A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer | NCT03024580 | Breast Neoplasm | Megestrol Aceta... Anastrozole 1Mg... Letrozole 2.5Mg... Exemestane 25 M... Tamoxifen 20Mg ... Fulvestrant 50M... | - | Instituto Nacional de Cancer, Brazil | |
| Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | NCT00041275 | Liver Cancer | megestrol aceta... | 20 Years - | National Cancer Institute (NCI) | |
| Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer | NCT00002680 | Breast Cancer | filgrastim cyclophosphamid... megestrol aceta... melphalan tamoxifen citra... thiotepa conventional su... peripheral bloo... radiation thera... | 18 Years - | Yale University | |
| A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer | NCT03024580 | Breast Neoplasm | Megestrol Aceta... Anastrozole 1Mg... Letrozole 2.5Mg... Exemestane 25 M... Tamoxifen 20Mg ... Fulvestrant 50M... | - | Instituto Nacional de Cancer, Brazil | |
| A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer | NCT03024580 | Breast Neoplasm | Megestrol Aceta... Anastrozole 1Mg... Letrozole 2.5Mg... Exemestane 25 M... Tamoxifen 20Mg ... Fulvestrant 50M... | - | Instituto Nacional de Cancer, Brazil | |
| Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients. | NCT05380479 | Anorexia | Mirtazapine Megestrol Aceta... | 18 Years - 70 Years | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | |
| Phase II Study of Everolimus Beyond Progression | NCT02269670 | Estrogen Recept... HER2-negative B... Progesterone Re... Recurrent Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | everolimus anastrozole letrozole tamoxifen citra... fulvestrant megestrol aceta... | 19 Years - | Emory University | |
| Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer | NCT00031785 | Anorexia Cachexia Lung Cancer | megestrol aceta... radiation thera... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer | NCT00002680 | Breast Cancer | filgrastim cyclophosphamid... megestrol aceta... melphalan tamoxifen citra... thiotepa conventional su... peripheral bloo... radiation thera... | 18 Years - | Yale University | |
| Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer | NCT01943058 | Atypical Endome... Endometrial Ade... Recurrent Endom... Stage IA Endome... Stage IB Endome... Stage II Endome... Stage IIIA Endo... Stage IIIB Endo... Stage IIIC Endo... Stage IVA Endom... Stage IVB Endom... | megestrol aceta... levonorgestrel-... laboratory biom... questionnaire a... | 18 Years - 44 Years | University of Southern California | |
| Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer | NCT00016341 | Endometrial Can... | filgrastim cisplatin doxorubicin hyd... megestrol aceta... paclitaxel tamoxifen citra... | - | GOG Foundation | |
| Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss | NCT00004912 | Cachexia Fatigue Unspecified Adu... | megestrol aceta... physical therap... | 18 Years - | Northwestern University | |
| Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite | NCT01501396 | Anorexia | Megestrol Aceta... Mirtazapine | 18 Years - | Washington University School of Medicine | |
| Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite | NCT00031707 | Anorexia Cachexia | eicosapentaenoi... megestrol aceta... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy | NCT03671811 | Atypical Endome... Endometrial Car... | Megestrol Aceta... Pterostilbene | 18 Years - | City of Hope Medical Center | |
| Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer | NCT00016341 | Endometrial Can... | filgrastim cisplatin doxorubicin hyd... megestrol aceta... paclitaxel tamoxifen citra... | - | GOG Foundation | |
| High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma | NCT00002465 | Breast Cancer Endometrial Can... Malignant Mesot... | megestrol aceta... | 18 Years - | National Cancer Institute (NCI) | |
| Phase II Study of Everolimus Beyond Progression | NCT02269670 | Estrogen Recept... HER2-negative B... Progesterone Re... Recurrent Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | everolimus anastrozole letrozole tamoxifen citra... fulvestrant megestrol aceta... | 19 Years - | Emory University | |
| Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients | NCT04939090 | Advanced Malign... Anorexia Hematopoietic a... | Olanzapine Megestrol Aceta... Questionnaire A... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients. | NCT05380479 | Anorexia | Mirtazapine Megestrol Aceta... | 18 Years - 70 Years | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | |
| Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer | NCT01943058 | Atypical Endome... Endometrial Ade... Recurrent Endom... Stage IA Endome... Stage IB Endome... Stage II Endome... Stage IIIA Endo... Stage IIIB Endo... Stage IIIC Endo... Stage IVA Endom... Stage IVB Endom... | megestrol aceta... levonorgestrel-... laboratory biom... questionnaire a... | 18 Years - 44 Years | University of Southern California | |
| Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy | NCT01200602 | Anorexia Weight Changes | megestrol aceta... clinical observ... | - 21 Years | Mayo Clinic | |
| Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers | NCT05538897 | FIGO Grade 1 En... FIGO Grade 2 En... Metastatic Endo... Recurrent Endom... Stage IV Uterin... | Biospecimen Col... Computed Tomogr... Ipatasertib Magnetic Resona... Megestrol Aceta... | 18 Years - | National Cancer Institute (NCI) | |
| Phase II Study of Everolimus Beyond Progression | NCT02269670 | Estrogen Recept... HER2-negative B... Progesterone Re... Recurrent Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | everolimus anastrozole letrozole tamoxifen citra... fulvestrant megestrol aceta... | 19 Years - | Emory University | |
| Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer | NCT00006799 | Anorexia Cachexia Head and Neck C... Quality of Life | megestrol aceta... quality-of-life... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol | NCT03777930 | Cancer, Therapy... | Chemotherapy dr... thalidomide and... optimal support... thalidomide and... | 18 Years - | Shenzhen Fifth People's Hospital | |
| Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer | NCT00031785 | Anorexia Cachexia Lung Cancer | megestrol aceta... radiation thera... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer | NCT01237327 | Metastatic Brea... | Megestrol aceta... exemestane (Aro... | - | Pfizer | |
| Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer | NCT05332483 | Endometrial Can... | Megestrol Aceta... | 18 Years - | Sunnybrook Health Sciences Centre | |
| Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite | NCT01501396 | Anorexia | Megestrol Aceta... Mirtazapine | 18 Years - | Washington University School of Medicine | |
| Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer | NCT00070148 | Unspecified Adu... Weight Changes | Megestrol Aceta... Oxandrolone 20 ... | 18 Years - | Wake Forest University Health Sciences | |
| The Safety and Effect Study of Acupuncture for Anorexia in Patients With Gastrointestinal Tract and Lung Cancers | NCT02619266 | Anorexia Cancer Cachexia | Acupuncture Sham Acupunctur... Megestrol Aceta... Placebo(Megestr... | 18 Years - | Xinqiao Hospital of Chongqing | |
| Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features | NCT05255653 | Endometrial Can... | Olaparib Pelvic external... Chemotherapy Durvalumab Medroxyprogeste... Megestrol Aceta... Vaginal brachyt... Observation | 18 Years - | Leiden University Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
